A short and convenient synthesis of 1-deoxymannojirimycin and N-oxy analogues from D-fructose

Journal of Organic Chemistry

Volumn 74, Issue 4, 2009, Pages 1766-1769

  Racine, Emilie ^a   Bello, Claudia ^b   Sandrine, Gerber Lemaire ^b   Vogel, Pierre ^a   Py, Sandrine ^a  

^a UNIVERSITÉ JOSEPH FOURIER   (France)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; 2 (HYDROXYMETHYL)PIPERIDINE 1,3,4,5 TETRAOL; ALPHA GLUCOSIDASE; BETA GLUCOSIDASE; BETA MANNOSIDASE; CISPLATIN; FRUCTOSE; MANNOSE; NATURAL PRODUCT; NITRONE; OLIGOSACCHARIDE; PIPERIDINE DERIVATIVE; TYROSINE TRANSFER RNA LIGASE; TYROSYL 2 AMINO 2 (2,4,5,8 TETRAHYDROXY 7 OXA 2 AZABICYCLO[3.2.1]OCT 3 YL)ACETIC ACID; UNCLASSIFIED DRUG; XYLAN 1,4 BETA XYLOSIDASE;

ALMOND; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASPERGILLUS NIDULANS; CANCER CELL CULTURE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME PURIFICATION; HEAD AND NECK CARCINOMA; HEPATITIS B VIRUS; MICROMONOSPORA; NONHUMAN; RICE; SNAIL; SYNTHESIS;

EID: 64349095821     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo802255t     Document Type: Article

References (87)

1. (a) Compain, P.; Martin, O. R. Iminosugars: From Synthesis to Therapeutic Applications; Wiley: Chichester, 2007.
2. (b) Stutz, A. E. Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond; Wiley-VCH: Weinheim, 1999.
3. (a) Legler, G. Adv. Carbohydr. Chem. Biochem. 1990, 48, 319.
4. (b) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. 1999, 38, 750.
5. (c) Zechel, D. L.; Withers, S. G. Acc. Chem. Res. 2000, 33, 11.
6. (d) Lillelund, V. H.; Jensen, H. H.; Liang, X.; Bols, M. Chem. Rev. 2002, 102, 515.
7. (a) Robina, I.; Moreno-Vargas, A. J.; Carmona, A. T.; Vogel, P. Curr. Drug Metab. 2004, 5, 329.
8. (b) Greimel, P.; Spreitz, J.; Stutz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003, 3, 513.
9. (a) Wrodnigg, T. M.; Steiner, A. J.; Ueberbacher, B. J. Anti-Cancer Agents Med. Chem. 2008, 8, 77.
10. (b) Gerber-Lemaire, S.; Juillerat-Jeanneret, L. Mini- Rev. Med. Chem. 2006, 6, 1043.
11. (a) Butters, T. D.; Dwek, R. A.; Platt, F. M. Chem. Rev. 2000, 100, 4683.
12. (b) Fan, J.-Q. Trends Pharmacol. Sci. 2003, 24, 355.
13. For reviews see: (a) Afarinkia, K.; Bahar, A. Tetrahedron: Asymmetry 2005, 16, 1239.
14. (b) Pearson, M. S. M.; Mathe-Allainmat, M.; Fargeas, V.; Lebreton, J. Eur. J. Org. Chem. 2005, 2159.
15. (c) Ayad, T.; Genisson, Y.; Baltas, M. Curr. Org. Chem. 2004, 8, 1211.
16. (d) Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003, 59, 2953.
17. (a) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645.
18. (b) Asano, N. Glycobiology 2003, 13, 93R.
19. Winkler, D. A.; Holan, G. J. Med. Chem. 1989, 32, 2084.
20. van den Elsen, J. M. H.; Kuntz, D. A.; Rose, D. R. EMBO J. 2001, 20, 3008.
21. Fuhrman, U.; Bause, E.; Legler, G.; Ploegh, H. Nature 1984, 307, 755.
22. Noda, I.; Fujeda, S.; Seki, M.; Tanaka, N.; Sunaga, H.; Ohtsubo, T.; Tsuzuki, H.; Fan, G.-K.; Saito, H. Int. J. Cancer 1999, 80, 279.
23. Metha, A.; Conyers, B.; Tyrrell, D. L. J.; Walters, K.-A.; Tipples, G. A.; Dwek, R. A.; Block, T. M. Antimicrob. Agents Chemother. 2002, 46, 4004.
24. Tatsuta, K.; Miura, S.; Ohta, S.; Gunji, H. J. Antibiot. 1995, 48, 286.
25. Tatsuta, K.; Ikeda, Y.; Miura, S. J. Antibiot. 1996, 49, 836.
26. (a) Carmona, A. T.; Wightman, R. H.; Robina, I.; Vogel, P. Helv. Chim. Acta 2003, 86, 3066.
27. (b) Desvergnes, S.; Py, S.; Vallee, Y. J. Org. Chem. 2005, 70, 1459.
28. (c) Desvergnes, S.; Desvergnes, V.; Martin, O. R.; Itoh, K.; Liu, H.- W.; Py, S. Bioorg. Med. Chem. 2007, 15, 6443.
29. (d) Pillard, C.; Desvergnes, V.; Py, S. Tetrahedron Lett. 2007, 48, 6209.
30. (a) Desvergnes, S.; Vallee, Y.; Py, S. Org. Lett. 2008, 10, 2967.
31. (b) Liautard, V.; Desvergnes, V.; Martin, O. R. Tetrahedron: Asymmetry 2008, 19, 1999.
32. (a) Kajimoto, T.; Liu, K. K.-C.; Pederson, R. L.; Zhong, Z.; Ichikawa, Y.; Porco Jr, J. A.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6187.
33. (b) Dong, W.; Jespersen, T.; Bols, M.; Skrydstrup, T.; Sierks, M. R. Biochemistry 1996, 35, 2788.
34. (c) Sun, L.; Li, P.; Landry, D. W.; Zhao, K. Tetrahedron Lett. 1996, 37, 1547.
35. (d) O'Neil, I. A.; Southern, J. M. Tetrahedron Lett. 1998, 39, 9089.
36. (a) Stefanska, A. L.; Coates, N. J.; Mensah, L. M.; Pope, A. J.; Ready, S. J.; Warr, S. R. J. Antibiot. 2000, 53, 345.
37. (b) Berge, J. M.; Houge-Frydrych, C. S. V.; Jarvest, R. L. J. Chem. Soc., Perkin Trans. 1 2001, 2521.
38. For a recent review on enantiopure cyclic nitrones, see: Revuelta, J.; Cicchi, S.; Goti, A.; Brandi, A. Synthesis 2007, 485.
39. For representative examples, see:(a) Goti, A.; Cicchi, S.; Mannucci, V.; Cardona, F.; Guarna, F.; Merino, P.; Tejero, T. Org. Lett. 2003, 5, 4235.
40. (b) Evans, G. B.; Furneaux, R. H.; Hausler, H.; Larsen, J. S.; Tyler, P. C. J. Org. Chem. 2004, 69, 2217.
41. (c) Yu, C.-Y.; Huang, M.-H. Org. Lett. 2006, 8, 3021.
42. (d) Gurjar, M. K.; Borhade, R. G.; Puranik, V. G.; Ramana, C. V. Tetrahedron Lett. 2006, 47, 6979.
43. (e) Kaliappan, K. P.; Das, P. Synlett 2008, 841. See also ref 15d.
44. For representative examples, see: (a) Cardona, F.; Faggi, E.; Liguori, F.; Cacciarini, M.; Goti, A. Tetrahedron Lett. 2003, 44, 2315.
45. (b) Toyao, A.; Tamura, O.; Takagi, H.; Ishibashi, H. Synlett 2003, 35.
46. (c) Alibes, R.; Blanco, P.; de March, P.; Figueredo, M.; Font, J.; Alvarez-Larena, A.; Piniella, J. F. Tetrahedron Lett. 2003, 44, 523.
47. (d) Chevrier, C.; LeNouen, D.; Neuburger, M.; Defoin, A.; Tarnus, C. Tetrahedron Lett. 2004, 45, 5363.
48. (e) Cicchi, S.; Marradi, M.; Vogel, P.; Goti, A. J. Org. Chem. 2006, 71, 1617.
49. (f) Liautard, V.; Christina, A. E.; Desvergnes, V.; Martin, O. R. J. Org. Chem. 2006, 71, 7337.
50. (g) Coutouli-Argyropoulou, E.; Xatzis, C.; Argyropoulos, N. G. Nucleosides, Nucleotides Nucleic Acids 2008, 27, 84.
51. See ref 15b and 15c. (a) Peer, A.; Vasella, A. Helv. Chim. Acta 1999, 82, 1044.
52. (b) Berge, J. M.; Copley, R. B. C.; Eggleston, D. S.; Hamprecht, D. W.; Jarvest, R. L.; Mensah, L. M.; O'Hanlon, P. J.; Pope, A. J. Bioorg. Med. Chem. Lett. 2000, 10, 1811.
53. (c) Duff, F. J.; Vivien, V.; Wightman, R. H. J. Chem. Soc., Chem. Commun. 2000, 2127.
54. (d) Tamura, O.; Toyao, A.; Ishibashi, H. Synlett 2002, 1344.
55. (a) Thesing, J.; Mayer, H. Chem. Ber. 1956, 89, 2159.
56. (b) Ali, S. A.; Wazeer, M. I. M. J. Chem. Soc., Perkin Trans. 2 1986, 1789.
57. (c) van den Broek, L. A. G. M. Tetrahedron 1996, 52, 4467.
58. (d) Chackalamannil, S.; Wang, Y. Tetrahedron 1997, 53, 11203.
59. (e) Brandi, A.; Cicchi, S.; Paschetta, V.; Gomez Pardo, D.; Cossy, J. Tetrahedron Lett. 2002, 43, 9357.
60. See also ref 23a.
61. See for example: (a) Herczegh, P.; Kovacs, I.; Szilagyi, L.; Varga, T.; Dinya, Z.; Sztaricskai, F. Tetrahedron Lett. 1993, 34, 1211.
62. (b) Markandu, J.; Dondas, H. A.; Frederickson, M.; Grigg, R. Tetrahedron 1997, 53, 13165.
63. (c) Ooi, H.; Urushibara, A.; Esumi, T.; Iwabuchi, Y.; Hatakeyama, S. Org. Lett. 2001, 3, 953.
64. D-Fructose as been previously used as a starting material for iminosugar syntheses: (a) Furneaux, R. H.; Tyler, P. C.; Whitehouse, L. A. Tetrahedron Lett. 1993, 34, 3613.
65. (b) Spreitz, J.; Stutz, A. E.; Wrodnigg, T. M. Carbohydr. Res. 2002, 337, 183.
66. (c) Izquierdo, I.; Plaza, M. T.; Rodriguez, M.; Franco, F.; Martos, A. Tetrahedron 2005, 61, 11697.
67. (a) Raaijmakers, H. W. C.; Arnouts, E. G.; Zwanenburg, B.; Chittenden, G. J. F. Carbohydr. Res. 1994, 257, 293.
68. (b) Sung'hwa, F.; Strik, A.; Regeling, H.; Zwanenburg, B.; Chittenden, G. J. F. Carbohydr. Res. 2006, 341, 846.
69. See Supporting Information. (a) Battaro, J. C.; Bedford, C. D.; Dodge, A. Synth. Commun. 1985, 15, 1333.
70. (b) Denmark, S. E.; Dappen, M. S.; Sear, N. L.; Jacobs, R. T. J. Am. Chem. Soc. 1990, 112, 3466.
71. Azeotropic elimination of water proved necessary for complete conversion of the starting material.
72. 1H NMR spectra.
73. Clark, J. H. J. Chem. Soc., Chem. Commun. 1978, 789.
74. Pilcher, A. S.; DeShong, P. J. Org. Chem. 1996, 61, 6901.
75. 4), with catalytic amounts of KCN, or excesses of hydroxylamine hydrochloride only led to recovery of the starting material, together with products of decomposition.
76. (a) Gossinger, E. Monat. Chem. 1982, 113, 495.
77. (b) Merino, P.; Revuelta, J.; Tejero, T.; Cicchi, S.; Goti, A. Eur. J. Org. Chem. 2004, 776.
78. (c) Marradi, M.; Cicchi, S.; Delso, J. I.; Rosi, L.; Tejero, T.; Merino, P.; Goti, A. Tetrahedron Lett. 2005, 46, 1287.
79. (d) Zhang, H.-L.; Zhao, G.; Ding, Y.; Wu, B. J. Org. Chem. 2005, 70, 4954.
80. (e) Yang, S.-H.; Caprio, V. Synlett 2007, 1219.
81. (f) Merino, P.; Delso, I.; Tejero, T.; Cardona, F.; Marradi, M.; Faggi, E.; Parmeggiani, C.; Goti, A. Eur. J. Org. Chem. 2008, 2929.
82. Kende, A. S.; Mendoza, J. S. Tetrahedron Lett. 1991, 32, 1699.
83. Compound 13 exhibits spectral data differing from that of its C-5 epimer: Sawada, D.; Takahashi, H.; Ikegami, S. Tetrahedron Lett. 2003, 44, 3085.
84. Xu, Y.-M.; Zhou, W.-S. J. Chem. Soc., Perkin Trans. 1 1997, 741.
85. Racine, E.; Philouze, C.; Py, S. J. Chem. Cryst. 2009, doi 10.1007/s10870-008-9506-8.
86. Brandi, A.; Cicchi, S.; Cordero, F. M.; Frignoli, R.; Goti, A.; Picasso, S.; Vogel, P. J. Org. Chem. 1995, 60, 6806.
87. See Supporting Information. For recent work on cyclic nitrones as radical traps, see: Han, Y.; Tuccio, B.; Lauricella, R.; Rockenbauer, A.; Zweier, J. L.; Villamena, F. A. J. Org. Chem. 2008, 73, 2533, and references therein.